Barclays Forecasts Strong Price Appreciation for Yum! Brands (NYSE:YUM) Stock
Barclays raised their price target on shares of Yum! Brands from $162.00 to $165.00 and gave the company an “overweight” rating in a report on Friday.
Source link
Similar Posts
What Gold’s Aggressive Move Is Really Telling Us – Fat Tail Daily
And there it goes. Gold just blasted through US$4,100 an ounce. It’s a major signal. And if you know how to read it, it’s screaming three things at us right now. The US-China trade truce won’t last First, gold’s surge is telling us that the so-called US-China trade truce is temporary. At best. Sure, China…
Devyani International Shares Surge 8% on Merger News; Sapphire Foods Slip 3.75%
January 2, 2026January 2, 2026 Shares of Devyani International Ltd surged 8% on 2nd January, while Sapphire Foods India Ltd fell 3.75%. This occurred after the long-anticipated merger of Yum Brands’ India franchisees was officially announced. Notably, Sapphire Foods’ board has approved its amalgamation with Devyani International. Under the…
Linkfest: 05 June, 2026
Some stuff I am reading today morning: RBI policy decision today (HT) Why SME IPOs are firing (MC) LIC stake in Rajesh Exports under scrutiny (FE) Amazon is Fortune 500’s top company (NY Post) Anthropic overtakes Open AI (Sherwood) Valuing SpaceX (Aswath Damodaran) Broadcom’s selloff creates megacap history (Yahoo) All poverty is energy poverty (Omnibudsman)…
Fuchs SE 2025 Q4 – Results – Earnings Call Presentation (OTCMKTS:FUPBY) 2026-03-20
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with…
Oramed Pharmaceuticals (NASDAQ:ORMP) Posts Earnings Results, Misses Expectations By $0.01 EPS
Oramed Pharmaceuticals (NASDAQ:ORMP – Get Free Report) announced its quarterly earnings results on Thursday. The biotechnology company reported ($0.05) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.01). Source link
IDP Education Limited (IDPUF) Shareholder/Analyst Call Transcript
Tracey Horton Good morning. Welcome to IDP Education’s 2025 Annual General Meeting. My name is Tracey Horton, and I’m the Chair of your company. It’s now 9:30 a.m. and as there is a quorum present, the meeting is now open. I would like to begin by acknowledging the traditional owners of the land on which…
